METASTATIC RENAL CELL CARCINOMA ( MRCC)
Clinical trials for METASTATIC RENAL CELL CARCINOMA ( MRCC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA ( MRCC) trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA ( MRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a scan let kidney cancer patients take a drug holiday?
Disease control Recruiting nowThis study is for people with advanced kidney cancer whose disease is well-controlled after at least a year of combination therapy (immunotherapy plus a targeted drug). Researchers want to see if PET/CT scans can identify who can safely pause treatment without the cancer growing …
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 26, 2026 07:45 UTC
-
New triple therapy aims to stop kidney cancer from spreading further
Disease control Recruiting nowThis study tests a new drug (IMSA101) that wakes up the immune system, combined with precise radiation and an immunotherapy drug (nivolumab), for people with metastatic kidney cancer that has started to grow in a few spots. The goal is to see if this combination can delay the can…
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New hope for kidney cancer: triple-drug combo enters phase 2 trial
Disease control Recruiting nowThis study tests three different drug combinations in 120 people with advanced kidney cancer that has spread. One group gets a new two-drug combo (fianlimab and cemiplimab), another adds a third drug (ipilimumab), and the third gets the current standard treatment. The goal is to …
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Phase: PHASE2 • Sponsor: Brian Rini • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New hope for advanced kidney cancer: experimental drug enters human trials
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, in adults with advanced kidney cancer that has spread. The goal is to see if it is safe and can shrink tumors when given alone or with other cancer drugs. About 224 participants will receive the drug through an IV. This is an early-ph…
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Massive global study digs into immunotherapy success in kidney cancer
Knowledge-focused Recruiting nowThis study gathers information from 1,220 people with advanced kidney cancer who received immunotherapy combinations as their first treatment. Researchers aim to find out which patients respond best and why, by looking at tumor genetics and immune cells. The goal is to improve fu…
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Sponsor: Hospital of Macerata • Aim: Knowledge-focused
Last updated May 26, 2026 07:41 UTC